https://www.hgscience.com/blog-2 daily 0.75 2020-11-24 https://www.hgscience.com/blog-2/blog-post-title-one-rye6y monthly 0.5 2020-08-25 https://www.hgscience.com/blog-2/blog-post-title-two-w68z2 monthly 0.5 2020-05-20 https://www.hgscience.com/home daily 1.0 2026-01-04 https://images.squarespace-cdn.com/content/v1/5f907f2c62759d69d7a10c74/1603306060480-AZ9UG8ELMEIMNV7HKEWS/thisisengineering-raeng-mF6gB6hV5OU-unsplash.jpg Home - About Us H&G Science has over 20 years of experience in extracting, nature’s best kept secret, tocotrienols, at high purity, from natural red palm sources. These compounds, while naturally occurring, are very hard to extract at high purity and scale without our proprietary methodology. However, when the proper purity is achieved The results are astounding. Across neurological, oncological, anti-inflammatory research and other emerging applications high purity tocotrienols, and their have proved a game changer in study after study for mitigation and prevention of serious conditions like stroke, COVID, cancer, and inflammation. https://images.squarespace-cdn.com/content/v1/5f907f2c62759d69d7a10c74/1603306189451-2YVQ45KK3S3B24ONR9B9/michele-blackwell-przZDqzZKpk-unsplash.jpg Home - Our Story H&G Science’s mission is to provide safer and more effective treatments for cancer and other diseases using sustainable naturally derived products. Our current primary focus is the use of tocotrienols to prevent and treat cancer and other diseases. Tocotrienols, which received GRAS (Generally Recognized As Safe) status from the FDA, are most easily obtained from the naturally occurring red palm fruit. They have been indicated as anti-cancer agents, radiation protecting agents, and preventive agents against many diseases and ailments. H&G Science is positioned to be the first and only supplier of the highly-purified tocotrienol products needed to enter this exciting new market. https://images.squarespace-cdn.com/content/v1/5f907f2c62759d69d7a10c74/1603567629396-OCXGC4O5233YEQJFVIY2/trust-tru-katsande-HQM5jm12etE-unsplash.jpg Home - The Opportunity We are actively looking for capital partners to help us flourish. We are uniquely positioned to grow at an unprecedented rate by expanding our research capabilities, market footprint and partnership networks. Let’s work together. https://images.squarespace-cdn.com/content/v1/5f907f2c62759d69d7a10c74/1605222465992-SD4T8C2XY1L71ZT7ZA3R/ed%2Bheadshotresizev2.jpg Home - Ed Glicken - CEO Ed has a formal background as an attorney and for nearly 25 years, he has headed operations and business development as CEO, President and VP of Operations at biotechnology companies. He is actively involved in relationships with key researchers and practitioners in natural cancer therapy development. https://images.squarespace-cdn.com/content/v1/5f907f2c62759d69d7a10c74/1605220469934-HJH6PNLVFGK82DFMZSDK/kevin%2Bheadshot.jpg Home - Kevin Henretta - CTO Kevin has a formal background in chemistry, 20 years of experience as a commercial scale drug production equipment Design Engineer, and 20 years of experience developing large-scale purification and extraction technologies. Kevin is a leading expert on tocotrienol extraction and purification, as well as other natural and synthetic product purification techniques. https://www.hgscience.com/research daily 0.75 2020-11-13 https://images.squarespace-cdn.com/content/v1/5f907f2c62759d69d7a10c74/1603569695997-N5Q70Y8AGJ74CPERN4IU/fluoroscopy-animals-greenville-sc-1200x859.jpg Research - Radiation Damage Prevention We are involved in discussions with a leading rectal cancer specialist at a major research institution who has conducted his own animal studies and seen the exciting radio-protectant properties of tocotrienols first-hand. Having personally witnessed the permanent, life altering damage caused by radiation therapy to thousands of patients, he believes this will have a great positive impact on both the success of the treatment and the quality of life for survivors. He has also demonstrated that tocotrienols, while protecting healthy cells from the harms of ionizing radiation, act to sensitize tumors to radiation treatments. He has submitted a proposal to team with us and perform a formal clinical trial with his patients to demonstrate the radiation-sensitizing effect of gamma-tocotrienol on colon cancer tumors. This provides an exciting opportunity to treat cancer patients with tocotrienol, as pre-clinical data suggests that tocotrienol treatment may also cause tumor shrinkage. Any clinical trial data will be used to facilitate further research and business opportunities. Our goal is to design the clinical trial so useful data will be obtained regarding potential tumor shrinkage during the pre-radiation gamma-tocotrienol regimen, potential protection of healthy tissue when gamma-tocotrienol is administered before the radiation procedure, and the primary focus of enhanced tumor sensitivity to radiation treatment when gamma-tocotrienol has been administered and accumulated in the tumor. https://images.squarespace-cdn.com/content/v1/5f907f2c62759d69d7a10c74/1603570851567-UJ4EDWP0FAMS3EUA9D3A/drew-beamer-XSp0RW7P1No-unsplash.jpg Research - Radiation Protection We have received a formal proposal to run Phase I/II human clinical trials on tocotrienol as a radiation protection agent for patients undergoing cardiac imaging procedures and the interventionalists performing the procedures. This particular opportunity paves the way to directly market an over-the-counter supplement to everyday consumers for protection against environmental radiation, as well as a more targeted single or double-dose regimen for patients undergoing these radiation intensive procedures. The initial target market will be practitioners and patients of the procedure, with expected expansion into a consumer over-the-counter health supplement business in the years to follow. https://images.squarespace-cdn.com/content/v1/5f907f2c62759d69d7a10c74/1603571174985-31LN2EPJLMN580B924TB/natasha-connell-byp5TTxUbL0-unsplash.jpg Research - Stroke Prevention Alpha-tocotrienol is the only isoform known to cross the blood-brain barrier. Studies performed at a leading research university on small animals have shown that tocotrienols act to prevent permanent damage caused by stroke and head trauma. H&G Science provided some of the tocotrienol material used in the research and has maintained contact with the researchers, who have left the institution and moved on to other areas of study. There is an opportunity to continue this work at another institution and ultimately run clinical trials to demonstrate the effectiveness of tocotrienols in preventing brain damage and swelling in humans. The potential market arising from positive data is quite significant. Having a supplement to protect against damage from head trauma would transform professional contact sports where head injuries are prevalent. Further, a supplement to protect against brain swelling has potential applications toward many brain-related diseases and acute conditions including depression. https://images.squarespace-cdn.com/content/v1/5f907f2c62759d69d7a10c74/1603571038939-2FUCAVTU4LX1ERN0JY3Y/piron-guillaume-U4FyCp3-KzY-unsplash.jpg Research - Cancer Treatment One of the leading cancer research institutes, under the direction of the gastrointestinal oncology department leader, is ready to enter Phase Ib/II clinical trials on the use of delta-tocotrienol for the prevention of pancreatic cancer metastasis after surgical tumor removal. They have recently received supplemental funding from a pharmaceutical company to initiate the clinical research. Compelling pre-clinical data has shown that delta-tocotrienol, when administered alongside the current standard of care, dramatically decreases the risk of pancreatic cancer recurrence in patients who have undergone tumor removal and colon resection surgery. Further data indicates that when administered as a maintenance dose, tocotrienol can delay or eliminate relapse in treated patients. This partner has submitted a proposal to team with us to perform a formal clinical trial to treat patients for a minimum of one year, with daily doses of delta-tocotrienol. We are currently in discussions with the sponsor pharmaceutical company to supply the tocotrienol for their trials. https://www.hgscience.com/tocotrienols daily 0.75 2020-11-13 https://images.squarespace-cdn.com/content/v1/5f907f2c62759d69d7a10c74/1603569205307-GCZ40C44GORXTQ93J3RZ/bret-kavanaugh-MIfUp3FA5ek-unsplash.jpg Tocotrienols - Cancer Prevention Cancer is the second leading cause of death in the United States today. We are currently working on clinical trials with major research institutions on the prospect of using tocotrienols to protect, treat, and keep patients in remission from a host of malignancies including gastrointestinal, pancreatic, and rectal cancer. Early stage results have been compelling and provide a huge opportunity to give patients and their families a fighting chance. https://images.squarespace-cdn.com/content/v1/5f907f2c62759d69d7a10c74/1603569596769-EJB7KZOZ1B7J453BIN2R/cdc-w9KEokhajKw-unsplash.jpg Tocotrienols - COVID-19 Prevention It is becoming increasingly clear that one of the key contributors to negative outcomes associated with COVID-19 is inflammation or circulatory issues prevalent in the second phase of the disease’s progression. Thus doctors are increasingly prescribing steroids and blood thinners to patients as part of a recovery regimen. There is evidence that tocotrienols can both speed recovery and mitigate the impact of this disease. https://images.squarespace-cdn.com/content/v1/5f907f2c62759d69d7a10c74/1603569695997-N5Q70Y8AGJ74CPERN4IU/fluoroscopy-animals-greenville-sc-1200x859.jpg Tocotrienols - Radiation Damage Prevention Radiation imaging can sometimes cause as many long-term health challenges as it can reveal in the short term. Procedures like Cardiac Fluoroscopy, or even X-ray machine operation, can present real, long term health risks for patients and health care workers alike. We are partnering with major research institutions to determine, through clinical trials, how effective tocotrienols can be at preventing the negative impact of this life saving technology. https://images.squarespace-cdn.com/content/v1/5f907f2c62759d69d7a10c74/1603569892587-E8I7M78D8JMU6GSAG4PW/natasha-connell-byp5TTxUbL0-unsplash.jpg Tocotrienols - Stroke Prevention Head trauma, and the brain swelling associated with it, is coming into focus as one of the most prevalent causes of stroke and other chronic neurological conditions like CTE. Tocotrienols have been found in small mammals to serve as one of the most efficient ways to cross the blood brain barrier and alleviate swelling while also arming the body to better circumvent clots. There is also promising data showing that this same treatment can lessen the impact of associated conditions like depression. https://www.hgscience.com/government daily 0.75 2020-11-13 https://images.squarespace-cdn.com/content/v1/5f907f2c62759d69d7a10c74/1603572492030-ZY2L3M0VU5UDQKG5WL43/dustin-humes-v2xURjCWdfQ-unsplash.jpg Government - How Governments Can Help Governments can and should be engines of innovation. They are among the only institutions that can make moonshots a reality. Shouldn’t one of those goals to be make cancer and other chronic diseases a distant memory? We are actively looking to work with governmental agencies of all levels to partner with us to conquer cancer and other diseases. https://www.hgscience.com/contact daily 0.75 2020-11-12 https://www.hgscience.com/investors daily 0.75 2020-11-13 https://images.squarespace-cdn.com/content/v1/5f907f2c62759d69d7a10c74/1603572720554-993MAZUK5YMN5G9DDHDE/adeolu-eletu-unRkg2jH1j0-unsplash.jpg Investors - Invest in Something Meaningful We are on the hunt for the right people to help us raise capital in order to fund further research and bring our products to market in an ethical, rapid, and profitable fashion. Because of our IP, experience, and existing partnerships, we are uniquely positioned to turn investment into rapid profitability. https://www.hgscience.com/healthcare daily 0.75 2020-11-13 https://images.squarespace-cdn.com/content/v1/5f907f2c62759d69d7a10c74/1603572129237-VRX7CEBCY00L8VCD53TS/h-shaw-hOfBn4jQEyo-unsplash.jpg Health Care Providers - How Health Care Providers can Help Health care providers are our natural allies and most important partners. We are looking to connect with physicians, interventionalists and hospital administrators to help further validate evidence about the efficacy of tocotrienols but more importantly to help you save lives while protecting your own safety. Let’s connect and start working together today. https://www.hgscience.com/about daily 0.75 2020-11-13 https://images.squarespace-cdn.com/content/v1/5f907f2c62759d69d7a10c74/1605232669598-V7M1OEAH5FBRKEXRKKJC/ed%2Bheadshotresizev2.jpg About Us - Ed Glicken - CEO Ed has a formal background as an attorney and for nearly 25 years, he has headed operations and business development as CEO, President and VP of Operations at biotechnology companies. He is actively involved in relationships with key researchers and practitioners in natural cancer therapy development. https://images.squarespace-cdn.com/content/v1/5f907f2c62759d69d7a10c74/1605220691610-0XLX92BYIX2N3873GZKV/kevin%2Bheadshot.jpg About Us - Kevin Henretta - CTO Kevin has a formal background in chemistry, 20 years of experience as a commercial scale drug production equipment Design Engineer, and 20 years of experience developing large-scale purification and extraction technologies. Kevin is a leading expert on tocotrienol extraction and purification, as well as other natural and synthetic product purification techniques. https://www.hgscience.com/tocoin daily 0.75 2020-11-13 https://images.squarespace-cdn.com/content/v1/5f907f2c62759d69d7a10c74/1605233611545-CUZ897E3VTYMVOMQ0XNH/r0YgTxk.jpg TocoCoin - Help Us Grow Many hands make light work. If you believe in what we’re doing as much as we do you can help us and profit as we grow. We want to democratize as much of our funding model as possible so we’ve initiated a token offering starting at $50. This will allow us to support further clinical trials, expand production and expand partner networks. https://www.hgscience.com/icontact daily 0.75 2020-11-13